The Croatian Phase I and II clinical trials for inflammatory bowel disease conducted in the 1990s by pharmaceutical company Pliva claimed safety with no significant toxicity, though complete peer-reviewed data never appeared in scientific literature beyond conference abstracts
The disagreement involved how to balance incomplete evidence, possible safety concerns, historical experience, patient demand, and the existing gray market
Systemic Mast Cell Activation Disease: The Role of Molecular Genetic Alterations in Pathogenesis, Heritability and Diagnostics. Immunology, vol
The evidence pattern from user experiences places acute soft tissue injuries at the top of the response hierarchy (60 to 70% report clear benefit), followed by muscle strains, gastrointestinal issues, and post-surgical recovery
We also offer intravenous glutathione administration in our office, where it is generally combined with a Modified Myers Cocktail, a form of intravenous micronutrient therapy
So what may cause a vitamin B12 overdose